Onco-Innovations Limited (CVE:ONCO) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Headlines Articles Press releases Onco-Innovations Limited

Home
Companies
Onco-Innovations Limited

BRIEF

published on 11/25/2025 at 22:35, 9 days 7 hours ago

Onco-Innovations Engages in University of Alberta's Innovation Awards

Cancer Research Innovation Awards Onco-Innovations PNKP Technology University Of Alberta
PRESS RELEASE

published on 11/25/2025 at 22:30, 9 days 7 hours ago

Onco-Innovations Attends University of Alberta's 2025 Innovation Awards
Onco-Innovations recognized at University of Alberta's 2025 Innovation Awards for advancing oncology innovation and commercializing PNKP Inhibitor Technology from university research

Innovation Awards Cancer Therapeutics Onco-Innovations University Of Alberta PNKP Inhibitor Technology
BRIEF

published on 11/21/2025 at 01:35, 14 days 4 hours ago

Onco-Innovations Advances PNKP Inhibitor Scale-Up with Dalton Partnership

Cancer Treatment Clinical Studies Dalton Pharma Services PNKP Inhibitor Manufacturing Optimization
PRESS RELEASE

published on 11/21/2025 at 01:30, 14 days 4 hours ago

Onco-Innovations Advances Optimization and Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services to Support Future Phase 1 Clinical Studies
Onco-Innovations partners with Dalton Pharma Services for A83B4C63 manufacturing optimization and scale-up activities, aiming for future clinical material production

Onco-Innovations Dalton Pharma Services Manufacturing Optimization Scale-up Activities Clinical Material Production
BRIEF

published on 11/19/2025 at 00:05, 16 days 6 hours ago

Onco-Innovations and Kuano Collaborate on PNKP Inhibitor Development

AI In Drug Discovery Onco-Innovations PNKP Inhibitor Kuano Quantum Analytics
PRESS RELEASE

published on 11/19/2025 at 00:00, 16 days 6 hours ago

Onco-Innovations Advances AI and Quantum Drug Discovery with Kuano Collaboration to Accelerate PNKP Inhibitor Technology Development
Onco-Innovations partners with Kuano Ltd. to accelerate development of PNKP Inhibitor Technology, leveraging quantum analytics for cancer therapeutics. Details on advanced collaboration

Cancer Therapeutics Onco-Innovations Quantum Analytics Kuano Ltd. PNKP Inhibitor Technology
BRIEF

published on 11/08/2025 at 00:05, 27 days 6 hours ago

Onco-Innovations' Inka Health Enhances Global Medical Data Use

Health Technology Oncology Real-world Evidence Rare Diseases Data Transportability
PRESS RELEASE

published on 11/08/2025 at 00:00, 27 days 6 hours ago

Onco-Innovations' Inka Health Publishes Framework on Transportability of Real-World Evidence and Use in Health Technology Assessment
Onco-Innovations Limited's subsidiary, Inka Health Corp., publishes primer on transportability of real-world evidence in oncology, outlining key statistical methods and potential impact on rare disease drug approvals

Oncology Real-world Evidence Rare Diseases Onco-Innovations Limited Inka Health Corp.
BRIEF

published on 10/31/2025 at 23:05, 1 month 4 days ago

Onco-Innovations Pursues Strategic U.S. Growth Following Investor Spotlight

Investor Relations Clinical Trials Cancer Treatment Onco-Innovations U.S. Strategy
PRESS RELEASE

published on 10/31/2025 at 23:00, 1 month 4 days ago

Onco-Innovations Provides Shareholder Update Following Cboe Canada Investor Spotlight
Onco-Innovations Limited updates strategic objectives focusing on U.S. strategy, including plans for clinical trials, U.S. stock exchange listing, and growth initiatives

Clinical Trials Stock Exchange Listing Growth Initiatives Onco-Innovations Limited U.S. Strategy

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 41 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 46 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 16 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 11 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 16 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 46 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 25 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 51 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours 1 minute ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 5 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 16 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 31 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 32 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 15 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE